Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0001048477-24-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-19 | 2024-03-15 | BMRN | Hardy Alexander | CEO, Dir | A - Grant | $0.00 | +32.8K | 148.2K | +28% | $0 |
| D | 2024-03-19 | 2024-03-15 | BMRN | Hardy Alexander | CEO, Dir | A - Grant | $0.00 | +44.0K | 44.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-15 | A | A | 32,780 | $0.00 | 148,151 | D | — | — | (F1) Restricted stock units granted March 15, 2024. Price not applicable. |
| 2 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-03-15 | A | A | 44,050 | $0.00 | 44,050 | D | $83.87 · 2025-03-15 to 2034-03-14 | 44,050 Common Stock | (F2) Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter. |